About FDA

How does FDA regulate tissue products? What safeguards are in place for recipients?

FDA regulates human cells or tissues intended for implantation, transplantation, infusion, or transfer into human recipients. These are referred to as human cells, tissue, and cellular and tissue-based products, or HCT/Ps. Examples of HCT/Ps include

  • bone
  • skin
  • corneas
  • ligaments
  • tendons
  • dura mater
  • heart valves
  • cell-based products
  • reproductive tissues including oocytes and semen

FDA focuses on three general areas of regulation:

  1. limiting the risk that a communicable disease may be transferred from a cell or tissue donor to the recipient
  2. establishing manufacturing practices that minimize the risk that cell or tissue products will be contaminated
  3. requiring cells and tissues that present greater risks due to their processing or their use to demonstrate safety and effectiveness

FDA does not regulate the transplantation of human organs containing blood vessels (such as kidney, liver, heart, lung or pancreas). The Health Resources Services Administration oversees human organs.

Page Last Updated: 05/31/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English